Researchers find new clue to treating aggressive Wilms tumor subtype
An international team, led by researchers at Nagoya University in Japan, may have determined why the diffuse anaplasia (DA) subtype of Wilms tumor (WT) resists chemotherapy.
Stay updated with breaking news from Modern Pathology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An international team, led by researchers at Nagoya University in Japan, may have determined why the diffuse anaplasia (DA) subtype of Wilms tumor (WT) resists chemotherapy.
HAIFA, Israel—A new Israeli technology that analyzes digitized biopsy images in real time enables the detection of cancer ...
Tel Aviv-based Imagene has developed AI models that can rapidly check for 28 biomarkers in eight organs.
The new technology can drastically speed up detection time for patients.
/PRNewswire/ -- Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, offering clinically validated, AI-based DeepDx®...